1. 1488PVemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial. (23rd October 2018) Authors: Mazières, J; Montané, L; Barlesi, F; Quantin, X; Trédaniel, J; Le Treut, J; Avrillon, V; Lavolé, A; Westeel, V; Orsini Piocelle, F; Pichon, E; Thiberville, L; Borel, C; Renault, P A; Jaffro, M; Collot, S; Ferretti, G; Legrand, F; Mahier Ait Oukhatar, C; Blay, J Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 90PReal-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database. (13th April 2019) Authors: Girard, N; Pérol, M; Simon, G; Audigier Valette, C; Gervais, R; Debieuvre, D; Schott, R; Quantin, X; Coudert, B; Lena, H; Carton, M; Robain, M; Filleron, T; Chouaid, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗